DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,756 | +3.8% | 15,138 | +0.4% | 2.64% | +7.5% |
| Q2 2023 | $3,619 | -8.5% | 15,080 | -4.0% | 2.45% | -7.7% |
| Q1 2023 | $3,957 | -4.4% | 15,701 | +0.7% | 2.66% | -7.6% |
| Q4 2022 | $4,140 | -99.9% | 15,597 | -1.0% | 2.88% | -7.0% |
| Q3 2022 | $4,068,000 | +17.8% | 15,751 | +15.6% | 3.09% | +21.9% |
| Q2 2022 | $3,453,000 | -16.5% | 13,620 | -3.4% | 2.54% | +14.1% |
| Q1 2022 | $4,134,000 | +10.7% | 14,094 | +24.1% | 2.22% | +16.9% |
| Q4 2021 | $3,735,000 | +12.4% | 11,353 | +4.0% | 1.90% | +3.2% |
| Q3 2021 | $3,324,000 | +16.5% | 10,917 | +2.7% | 1.84% | +27.7% |
| Q2 2021 | $2,852,000 | +24.4% | 10,628 | +4.3% | 1.44% | +15.1% |
| Q1 2021 | $2,293,000 | +1637.1% | 10,188 | +1612.3% | 1.26% | +1573.3% |
| Q4 2020 | $132,000 | +3.1% | 595 | +0.2% | 0.08% | -9.6% |
| Q3 2020 | $128,000 | +21.9% | 594 | 0.0% | 0.08% | +7.8% |
| Q2 2020 | $105,000 | +34.6% | 594 | +5.3% | 0.08% | +10.0% |
| Q1 2020 | $78,000 | -9.3% | 564 | +0.2% | 0.07% | +7.7% |
| Q4 2019 | $86,000 | +6.2% | 563 | 0.0% | 0.06% | -3.0% |
| Q3 2019 | $81,000 | +1.2% | 563 | +0.2% | 0.07% | -1.5% |
| Q2 2019 | $80,000 | +8.1% | 562 | +0.2% | 0.07% | +3.0% |
| Q1 2019 | $74,000 | +42.3% | 561 | +11.5% | 0.07% | +22.2% |
| Q4 2018 | $52,000 | -5.5% | 503 | +0.2% | 0.05% | +12.5% |
| Q3 2018 | $55,000 | +12.2% | 502 | +0.2% | 0.05% | +4.3% |
| Q2 2018 | $49,000 | 0.0% | 501 | +0.2% | 0.05% | -6.1% |
| Q1 2018 | $49,000 | +6.5% | 500 | 0.0% | 0.05% | +16.7% |
| Q4 2017 | $46,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |